IL10 and cancer: Even if our models cannot precisely mimic the local inflammatory microenvironment of OS, these preclinical results, together with the above-reported clinical data, provide a new understanding of the macrophage role and their inflammatory responses in OS, showing that inhibition of IL-10 signaling pathways could be a useful therapeutic approach that could be used for the development of new cancer immunotherapeutic strategies.